Exai Bio says novel RNA and AI-driven platform can detect early breast cancer
Exai Bio, a leader in healthcare innovation, announced groundbreaking data showcasing the efficacy of its novel RNA-based and AI-driven liquid biopsy platform in detecting breast ... Read More